Thus, given that the overexpression of MDR-associated ABC transporters is still an issue in cancer treatment, identifying drugs that can be pumped out from cancer cells could help to produce the maximal efficacy of cancer therapy, thereby potentially improving the patients’ quality of life. Here, ABCG2 is linked to cancer.